Cargando…
Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
BACKGROUND: The goal of this study was to perform candidate gene association with cytotoxicity of chemotherapeutics in cell line models through resequencing and discovery of rare and low frequency variants along with common variations. Here, an association study of cytotoxicity response to 30 FDA ap...
Autores principales: | Hariani, Gunjan D, Lam, Ernest J, Havener, Tammy, Kwok, Pui-Yan, McLeod, Howard L, Wagner, Michael J, Motsinger-Reif, Alison A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068968/ https://www.ncbi.nlm.nih.gov/pubmed/24924344 http://dx.doi.org/10.1186/1756-0500-7-360 |
Ejemplares similares
-
Erratum to: Application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics
por: Hariani, Gunjan D, et al.
Publicado: (2014) -
Identification and Replication of Loci Involved in Camptothecin-Induced Cytotoxicity Using CEPH Pedigrees
por: Watson, Venita Gresham, et al.
Publicado: (2011) -
A Comparison of Association Methods for Cytotoxicity Mapping in Pharmacogenomics
por: Brown, Chad, et al.
Publicado: (2011) -
Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines
por: Roell, Kyle R., et al.
Publicado: (2019) -
Multivariate methods and software for association mapping in dose‐response genome‐wide association studies
por: Brown, Chad C, et al.
Publicado: (2012)